Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Dr. Leighl's Highlights in Lung Cancer from 2012: MEK Inhibitor Therapy for KRAS Mutation-Positive NSCLC
Author
Howard (Jack) West, MD

Pre and post MEKiThe next portion of Dr. Leighl's "Highlights of Lung Cancer from 2012" webinar focused on exciting research presented at ASCO 2012 and very recently published on the potential efficacy of a new class of targeted therapy, called MEK inhibitors, for the large subset of patients who have a KRAS mutation. KRAS is the most common mutation seen in lung cancer, found in about 20-25% of patients with NSCLC, in different histologies and with different smoking histories, but we haven't had an effective therapy for this group of patients, in whom some evidence suggests that both EGFR inhibitors and standard chemotherapy are less effective.

Dr. Leighl's podcast discusses encouraging work that suggests a potential value in adding a MEK inhibitor to standard chemo, though ensuring that it's a tolerable combination is something we'll need to continue to work on (in addition to confirming the activity of MEK inhibitors in larger trials).  Here's her presentation in video and audio format, as well as the figures for it.

[powerpress]

Dr. Leighl Highlights in LC 2012 Pt 3 MEK for KRAS Mutn Audio Podcast

Dr. Leighl Highlights in LC 2012 Pt 3 MEK for KRAS Mutn Figs

Dr. Leighl's Highlights in Lung Cancer, 2012 program next turned to squamous cell carcinoma and anti-PD1 immunotherapy work, so look for that here very soon.  In the meantime, I hope you find this program helpful and promising!

 

Next Previous link

Previous PostNext Post

Related Content

Article
Recent Live Events with the Global Resource for Advancing Cancer Education ~ View the Full OnDemand Lung Cancer OncTalk from February 2024  
Image
Blood Cancer OncTalk 2023
Video
In this first batch of the Q&A Session of Blood Cancer OncTalk, Drs. Aaron Goodman, Sridevi Rajeeve, Tycel Phillips, Alakrita Taneja, and Marco Ruiz come together to answer questions from the attendees at our Blood Cancer OncTalk 2023 live event.  To watch the complete playlist click here.
Image
Blood Cancer OncTalk 2023
Video
This is the third batch of videos from the Blood Cancer OncTalk playlist. In these videos, Dr. Alankrita Taneja defines Smoldering Multiple Myeloma (SMM) and discusses how it differs from Multiple Myeloma (MM), risk factors and treatments.   To watch the complete playlist click here.

Forum Discussions

Hi Oaktowngrrl,  Welcome to Grace.  I'm so sorry you're going through this.

 

 Finding a reputable dedicated thoracic surgeon for lung surgery might be difficult, as it is a complex and...

Hello Hello,  Just want to let you know I see your post and will respond more appropriately in the morning. 

Recent Comments

JOIN THE CONVERSATION
Hi Oaktowngrrl,  Welcome to…
By JanineT GRACE … on
I can understand why you're…
By paulryan on
I'm so sorry to hear it.
By Andrian on
Hey,

 I'm sure you're…
By JanineT GRACE … on